$NOMA

Nomadar Corp.

CIK:0001994214|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 669,571	$ 312,633	$ 1,073,371	$ 499,570
Cost of sales	70,475	94,706	118,331	271,094
Gross profit	599,096	217,927	955,040	228,476
Operating expenses:
General and administrative expenses	304,069	45,953	807,080	91,412
Professional fees	259,252	458,607	818,552	712,604
Sales and marketing expenses	150,030		198,363
Loss (gain) on foreign currency transactions, net	109,791	(57,548)	133,856	(60,184)
Total operating expenses	823,142	447,012	1,957,851	743,832
Loss from operations	(224,046)	(229,085)	(1,002,811)	(515,356)
Other expense (income):
Change in fair value of convertible notes payable	247,755	32,938	868,962	32,938
Amortization of loan receivable premium	99,060		197,031
Interest expense	23,529	7,530	181,903	12,578
Interest income – related party	(154,449)	(11,795)	(223,812)	(11,795)
SEPA commitment fee and structuring fee		325,000		325,000
Loss from original issue discount on convertible note payable		40,000		40,000
Other expenses, net	215,895	393,673	1,024,084	398,721
Loss before provision for income taxes	(439,941)	(622,758)	(2,026,895)	(914,077)
Provision for income taxes
Net loss	$ (439,941)	$ (622,758)	$ (2,026,895)	$ (914,077)
Weighted average common shares outstanding, basic	16,969,716	14,104,968	16,809,778	14,093,093
Weighted average common shares outstanding, diluted	16,969,716	14,104,968	16,809,778	14,093,093
Net loss per share attributable to common stockholders basic	$ (0.03)	$ (0.04)	$ (0.12)	$ (0.06)
Net loss per share attributable to common stockholders diluted	$ (0.03)	$ (0.04)	$ (0.12)	$ (0.06)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities:
Net Loss	$ (2,026,895)	$ (914,077)
Loss from original issue discount on convertible note payable		40,000
Change in fair value of convertible note payable	868,962	32,938
Non-cash issuance of commitment shares in conjunction with convertible note payable		300,000
Amortization of loan receivable premium – related party	197,031
Foreign exchange gain on loan receivable – related party	205,889	(53,827)
Foreign exchange gain on related party finance lease	(136,607)
Accretion of deferred liability – related party	125,529	4,279
Interest on finance lease liability	47,024
Accretion of direct listing fee discount	9,350
Depreciation	356
Changes in operating assets and liabilities:
Accounts receivable	(105,128)	16,240
Interest receivable – related party	(115,372)	(11,795)
Prepaid expenses and other current assets	(486,103)	(9,122)
Accounts payable	(48,299)	773,751
Accrued expenses	264,702	(124,277)
Direct listing fees payable	(320,000)
Due to related party, net	251,344
Interest payable – stockholder loan		8,300
Deferred revenue	511,526	(8,324)
Net cash used in (provided by) operating activities	(756,691)	54,086
Cash Flows from Investing Activities:
Payments for receivable from agreement with investor	(2,000,000)
Proceeds from loan receivable – related party, denominated in Euros	3,572,502
Purchase of construction in progress costs	(761,994)
Purchase of equipment	(3,972)
Net cash provided by investing activities	806,536
Cash Flows from Financing Activities:
Proceeds from issuance of common stock from subscription agreement	1,938,257
Proceeds from issuance of common stock from capital contributions	5,882,860
Payments made on stockholder loan		(324,601)
Payments made on deferred liability – related party	(792,396)	(207,604)
Proceeds from contributed capital issued in advance for stock payable – related party		203,772
Payments toward finance lease	(70,071)
Payment toward purchase option of related party finance lease	(6,648,080)
Proceeds from convertible note payable, net of $40,000 discount		460,000
Net cash provided by financing activities	310,570	131,567
Net Change in Cash	360,415	185,653
Cash – Beginning of Period	78,163	417
Cash – End of Period	438,578	186,070
Noncash investing and financing activities:
Acquisition of loan receivable – related party for common stock issued and a deferred payment liability		8,711,035
Issuance of commitment shares in conjunction with convertible note payable		300,000
Conversion of convertible note and interest to common stock	726,799
Reclassification of land to property and equipment from right-of-use asset upon exercise of lease purchase option	$ 10,052,133

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash	$ 438,578	$ 78,163
Accounts receivable	290,329	185,201
Prepaid expenses and other current assets	498,908	12,805
Loan receivable – related party, denominated in Euros	4,537,589
Total current assets	5,765,404	276,169
Loan receivable – related party, denominated in Euros		8,513,011
Receivable from agreement with investor	2,000,000
Right-of-use asset		5,166,888
Property and equipment, net	10,817,743
Interest receivable – related party	250,209	134,837
Total assets	18,833,356	14,090,905
Current liabilities:
Accounts payable	1,405,696	1,453,995
Accrued expenses	540,668	275,966
Direct listing fees payable	443,504	609,237
Due to related party, net	269,439	18,095
Convertible notes payable – at fair value	1,788,826	1,646,663
Lease liability – current portion		15,927
Deferred revenue	676,084	164,558
Total current liabilities	5,124,217	4,184,441
Direct listing fees payable - noncurrent		144,917
Lease liability – long-term		1,906,562
Deferred liability – related party		666,867
Total liabilities	5,124,217	6,902,787
Commitments and contingencies (Note 3)
Stockholders’ equity:
Additional paid-in capital	19,915,887	11,367,974
Accumulated deficit	(6,206,766)	(4,179,871)
Total stockholders’ equity	13,709,139	7,188,118
Total liabilities and stockholders’ equity	18,833,356	14,090,905
Common Class A [Member]
Stockholders’ equity:
Common stock; value	15	12
Common Class B [Member]
Stockholders’ equity:
Common stock; value	$ 3	$ 3